Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003

Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol

(2014) Katharine Patrick et al.   BRITISH JOURNAL OF HAEMATOLOGY

Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group

(2013) T. D. Buitenkamp et al.   BLOOD

Postinduction Dexamethasone and Individualized Dosing ofEscherichia ColiL-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01

(2013) Lynda M. Vrooman et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

(2013) Ajay Vora et al.   LANCET ONCOLOGY

Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

(2012) Stephen P. Hunger et al.   JOURNAL OF CLINICAL ONCOLOGY

Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples

(2011) M.-C. Ethier et al.   BLOOD

Impact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity*

(2011) Cornelis M. van Tilburg et al.   BRITISH JOURNAL OF HAEMATOLOGY

Infections and immunodeficiency in Down syndrome

(2011) G. Ram et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Life-threatening and Fatal Infections in Children With Acute Myeloid Leukemia

(2011) Lillian Sung et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

2011 ASPHO Abstracts

(2011)   PEDIATRIC BLOOD & CANCER

Myelosuppression and infectious complications in children with down syndrome and acute lymphoblastic leukemia

(2011) Karen R. Rabin et al.   PEDIATRIC BLOOD & CANCER

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

(2010) V. Conter et al.   BLOOD

The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers

(2010) Jennifer L. McNeer et al.   BRITISH JOURNAL OF HAEMATOLOGY

Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)

(2009) Anjo J Veerman et al.   LANCET ONCOLOGY

Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia

(2009) C H Pui et al.   LEUKEMIA

Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation

(2009) Ching-Hon Pui et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

(2008) A. Moricke et al.   BLOOD

Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with down syndrome

(2008) Niketa Shah et al.   PEDIATRIC BLOOD & CANCER

Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia

(2007) Ulrike B. Graubner et al.   PEDIATRIC BLOOD & CANCER